mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.06 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.06 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.06 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.07 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |